EP-1577: Prostate cancer SBRT dose escalation to the dominant nodule/s: Phase I and immunological effects. (April 2018) - Herrera, F.; Valerio, V.; Harari, A.; Berthold, B.; Meuwly, J.Y.; Valle, V.; Coukos, G.; Jichlinski, P.; Bourhis, J.